Lurbinectedin
id:
lurbinectedin-315-13439390
title:
Lurbinectedin
text:
Lurbinectedin, sold under the brand name Zepzelca, is a medication used for the treatment of small cell lung cancer. The most common side effects include leukopenia, lymphopenia, fatigue, anemia, neutropenia, increased creatinine, increased alanine aminotransferase, increased glucose, thrombocytopenia, nausea, decreased appetite, musculoskeletal pain, decreased albumin, constipation, dyspnea, decreased sodium, increased aspartate aminotransferase, vomiting, cough, decreased magnesium and diarrhe
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Lurbinectedin
date created:
date modified:
2023-09-19T07:20:40Z
main entity:
{"identifier":"Q27254568","url":"https://www.wikidata.org/entity/Q27254568"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8f/Lurbinectedin_structure.svg","width":512,"height":357}
fields total:
13
integrity:
15